Rheumatology Information Service Europe
Kineret FAQs: Indication
« Go back to Overview

Q5: What is the therapeutic indication for Kineret® in Europe?
» Read answer

Q6: When was Kineret® approved for the treatment of rheumatoid arthritis (RA)?
» Read answer



« Go back to Overview

Downloads

Kineret® Summary of Product Characteristics
» View document
» Download document


© 2008 Biovitrum AB (publ). All rights reserved.
This is a European website containing information about Kineret® (anakinra) and is intended for healthcare professionals within the European Union. The information on this site is not country-specific and may contain product-related information that is outside the approved product data sheet in the country in which you are located.
» Privacy Policy     » Terms of Use     » Contact Us